Antibiotic composition with inhibitor

Details for Australian Patent Application No. 2001239869 (hide)

Owner Advancis Pharmaceutical Corporation

Inventors Rudnic, Edward M.

Agent Spruson & Ferguson

Pub. Number AU-B-2001239869

PCT Pub. Number WO01/62231

Priority 60142582 24.02.00 US

Filing date 23 February 2001

Wipo publication date 3 September 2001

Acceptance publication date 15 December 2005

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/43 (2006.01)

A61K 31/545 (2006.01) - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

15 December 2005 Application Accepted

  Published as AU-B-2001239869

13 April 2006 Standard Patent Sealed

2 April 2009 Alteration of Name

  The name of the patentee has been altered to MiddleBrook Pharmaceuticals, Inc. 2002

21 April 2011 Assignment Registered

  MiddleBrook Pharmaceuticals, Inc. The patent has been assigned to Victory Pharma, Inc.

20 October 2011 Assignment Registered

  Victory Pharma, Inc. The patent has been assigned to Shionogi, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001239870

2001239868-Method and apparatus for tab printing